Approved Monoclonal Antibody Therapies for Hidradenitis Suppurativa

JAMA Dermatology · Published 2026-08-05 · DOI 10.1001/jamadermatol.2026.2633

Free full text

Authors (5)

James Pham, Tara Sholji, Marra Aghajani, Cindy Kok, John W. Frew

Abstract

PubPorta does not have an abstract for this article yet.

Read the article at the publisher →

Publication details

Year

2026

Citation

Pham, J., Sholji, T., Aghajani, M., et al. (2026). Approved Monoclonal Antibody Therapies for Hidradenitis Suppurativa. JAMA Dermatology. https://doi.org/10.1001/jamadermatol.2026.2633

Related articles

• JAMA+ Trials Editor’s Choice for Clinical Trial of 2025 in JAMA Dermatology · JAMA Dermatology · 2026 · Same journal
• GLP-1 Receptor Agonist Use and Clinical Outcomes in Patients With Hidradenitis Suppurativa · JAMA Dermatology · 2026 · Same journal
• Dyschromatosis and Blistering in a Young Male · JAMA Dermatology · 2026 · Same journal
• JAMA Dermatology · JAMA Dermatology · 2026 · Same journal
• Progression From Acute to Chronic Urticaria · JAMA Dermatology · 2026 · Same journal
• Characterizing Dermoscopic Features of Longitudinal Melanonychia in Skin of Color · JAMA Dermatology · 2026 · Same journal
• Melasma · JAMA Dermatology · 2026 · Same journal
• Error in Title · JAMA Dermatology · 2026 · Same journal
• Early Respiratory Infection Burden and Atopic Dermatitis in Childhood · JAMA Dermatology · 2026 · Same journal
• Commercial Price Variation for Common Dermatologic Procedures · JAMA Dermatology · 2026 · Same journal